Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance

NCT03509441 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03509441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03509441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
January 15, 2015
Completion date
November 11, 2019
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac fibrosis, cardiomyopathies, diabetes, insulin resistance, non-ischemic cardiomyopathy